Malignant Cardiovascular Neoplasm — Trials

Malignant Cardiovascular Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

196 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 37
Recruiting: 23
Ph III recruiting: 0
Growth YoY: —
Industry share: 14%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (21)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05799612	Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma	withdrawn	Phase 1	0	M.D. Anderson Cancer CenterOTHER	0	Feb 13, 2026	clinicaltrials
NCT02229981	Early Phase Evaluation of ABC294640 in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma or Kaposi Sarcoma(ABC-102)	withdrawn	Phase 1 / Phase 2	0	RedHill Biopharma LimitedINDUSTRY	1	Dec 7, 2017